Zusammenfassung
Die bronchiale Thermoplastie ist eine seit 2011 zugelassene Therapieoption für Patienten mit schwerem Asthma bronchiale, die trotz maximal ausgeschöpfter medikamentöser Therapie weiterhin ein unkontrolliertes Asthma aufweisen. Ziel dieser interventionellen Therapie ist es, durch kontrollierte endobronchiale Applikation von Wärme die Masse der glatten Muskulatur in den zentralen und peripheren Atemwegen zu reduzieren, um die Symptome verursachende Bronchokonstriktion zu verringern. In randomisierten kontrollierten klinischen Studien konnten eine Abnahme der Exazerbationen, eine Zunahme der Lebensqualität, eine Reduktion der notfallmäßigen Arztbesuche sowie der Fehltage in der Schule oder bei der Arbeit gezeigt werden. Im kurzfristigen postinterventionellen Verlauf kommt es durch die bronchiale Thermoplastie zu einer Zunahme von Exazerbationen, häufigeren respiratorischen Infekten sowie der Notwendigkeit einer stationären Behandlung. Langfristig konnte in den bisher vorliegenden Studien in bis zu 5 Jahren nach der Behandlung eine klinische, funktionelle und radiologische Stabilität gezeigt werden. Weitere Studien zum Langzeitverlauf sowie zur genaueren Identifizierung eines auf das Verfahren gut ansprechenden Phänotyps sind notwendig.
Abstract
Since 2011 bronchial thermoplasty has been an approved treatment option for patients with severe bronchial asthma who remain symptomatic despite maximum pharmaceutical therapy. The aim of this interventional therapy option is the controlled reduction of smooth muscle in the central and peripheral airways in order to reduce symptomatic bronchoconstriction via the application of warmth. Randomized controlled clinical trials showed an increase in the quality of life, a decrease in emergency department visits as well as days lost from school or work and a reduction in severe exacerbations. Short-term adverse effects include an increase in exacerbation rates, increase in hospitalizations and an increase in respiratory infections. In the 5‑year follow-up of the long-term studies available there was evidence of clinical, functional and radiological stability of the treated patients. Further studies are necessary to identify an asthma phenotype which responds well to this treatment.
Abbreviations
- ACQ:
-
Asthma Control Questionnaire
- AIR:
-
Asthma Intervention Research
- AQLQ:
-
Asthma Quality of Life Questionnaire
- ASS:
-
Acetylsalicylsäure
- AWMF:
-
Arbeitsgemeinschaft der wissenschaftlichen medizinischen Fachgesellschaften
- BAL:
-
Bronchoalveoläre Lavage
- BRSK:
-
Bronchoskopie
- COPD:
-
Chronisch obstruktive Lungenerkrankung
- CT:
-
Computertomographie
- FEV1:
-
Exspiratorische Einsekundenkapazität („forced expiratory volume in 1 second“)
- ICD:
-
Implantierter Kardioverterdefibrillator
- IgE:
-
Immunglobulin E
- IL:
-
Interleukin
- NSAR:
-
Nichtsteroidale Antirheumatika
- OCT:
-
Optical coherence tomography
- PAS2:
-
Post-FDA approval clinical trial evaluation bronchial thermoplasty in severe persistent asthma
- RANTES:
-
Regulated upon activation, normal T‑cell expressed and secreted
- RISA:
-
Research in severe asthma
- TGF-ß:
-
Transformin-growth-factor-ß
- VC:
-
Vitalkapazität
Literatur
AWMF (2013) Nationale Versorgungs-Leitlinie Asthma, Version 5, August 2013. http://www.asthma.versorgungsleitlinien.de. Zugegriffen: 03.11.17
Baraldo S, Turato G, Bazzan E, Ballarin A, Damin M, Blestro E, Lokar Oliani K, Calabrese F, Maestrelli P, Snijders D, Barbato A, Saetta M (2011) Noneosinophilic asthma in children: relation with airway remodelling. Eur Respir J 38(3):575–583
Berger P, Girodet PO, Begueret H, Ousova O, Perng DW, Marthan R, Walls AF, Tunon de Lara JM (2003) Tryptase-stimulated human airway smooth musclecell induce cytokine synthesis and mastcell chemotaxis. Faseb J 17(14):2139–2141
Bicknell S, Chaudhuri R, Lee N, Shepherd M, Spears M, Pitman N, Cameron E, Cowan D, Nixon J, Thompson J, McSharry C, Thomson NC (2015) Effectiveness of bronchial thermoplasty in severe asthma in „real life“ patients compared with those recruited to clinical trials in the same centre. Ther Adv Respir Dis 9(6):267–271
Castro M, Rubin AS, Laviolette M, Fiterman J, De Andrade Lima M, Shah PL, Fiss E, Olivenstein R, Thomson NC, Niven RM, Pavord ID, Simoff M, Duhamel DR, McEvoy C, Barbers R, Ten Hacken NH, Wechsler ME, Holmes M, Phillips MJ, Erzurum S, Lunn W, Israel E, Jarjour N, Kraft M, Shargill NS, Quiring J, Berry SM, Cox G, AIR2 Trial Study Group (2010) Effectivness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med 181(2):116–124
Castro M, Rubin A, Laviolette M, Hanania NA, Armstrong B, Cox G, AIR2 Trial Study Group (2011) Persistence of effectiveness of bronchial thermoplasty in patients with severe asthma. Ann Allergy Asthma Immunol 107(1):65–70
Chupp G, Laviolette M, Cohn L, McEvoy C, Bansal S, Shifren A, Khatri S, Grubb GM, McMullen E, Strauven R, Kline JN (2017) Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: a comparison of 3‑year follow-up results from two prospective multicentre studies. Eur Respir J 50(2):1700017. https://doi.org/10.1183/13993003.00017-2017
Cox G, Miller JD, McWilliams A, Fitzgerald JM, Lam S (2006) Bronchial thermoplasty for asthma. Am J Respir Crit Care Med 173(9):965–969
Cox G, Thomson NC, Rubin AS, Niven RM, Corris PA, Siersted HC, Olivenstein R, Pavord ID, McCormack D, Chaudhuri R, Miller JD, Laviolette M, AIR Trial Study Group (2007) Asthma control during the year after bronchial thermoplasty. N Engl J Med 356(13):1327–1337
Danek CJ, Lombard CM, Dungworth DL, Cox PG, Miller JD, Biggs MJ, Keast TM, Loomas BE, Wizeman WJ, Hogg JC, Leff AR (2004) Reduction in airway hyperresponsiveness to methacholine by the application of RF energy in dogs. J Appl Physiol 97(5):1946–1953
Debray MP, Dombret MC, Pretolani M, Thabut G, Alavoine L, Brillet PY, Taillé C, Khalil A, Chanez P, Aubier M (2017) Early computed tomography modifications following bronchial thermoplasty in patients with severe asthma. Eur Respir J 49(3):1601565. https://doi.org/10.1183/13993003.01565-2016
Denner DR, Doeing DC, Hogarth DK, Dugan K, Naureckas ET, White SR (2015) Airway inflammation after bronchial thermoplasty for severe asthma. Ann Am Thorac Soc 12:1302–1309
D’Hooghe JNS, Ten Hacken NHT, Weesink EJM, Sterk PJ, Annema JT, Bonta PI (2017) Emerging understanding of the mechanism of action of bronchial thermoplasty in asthma. Pharmacol Ther 181:101–107. https://doi.org/10.1016/j.pharmthera.2017.07.015
Ding M, Chen Y, Guan WJ, Zhong CH, Jiang M, Luo WZ et al (2016) Measuring airway remodeling in patients with different COPD staging using endobronchial optical coherence tomography. Chest 150:1281–1290
Doeing DC, Mahajan AK, White SR, Naureckas ET, Krishnan JA, Hogarth DK (2013) Safety and feasibility of bronchial thermoplasty in asthma patients with very severe fixed airflow obstruction: a case series. J Asthma 50(2):215–218
Global initiative for Asthma (GINA) (2014) Update 2017. http://www.ginasthma.org. Zugegriffen: 03.11.17
Gordon IO, Husain AN, Charbeneau J, Krishnan JA, Hogarth DK (2013) Endbronchial biopsy: a guide for asthma therapy selection in the era of bronchial thermoplasty. J Asthma 50(6):634–641. https://doi.org/10.3109/02770903.2013.794239
Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA et al (1991) Optical coherence tomography. Science 254:1178–1181
Iikura M, Hojo M, Nagano N, Sakamoto K, Kobayashi K, Yamamoto S, Hashimoto M, Ishii S, Izumi S, Sugiyama H (2017) Bronchial thermoplasty for severe uncontrolled asthma in Japan. Allergol Int. https://doi.org/10.1016/j.alit.2017.07.006
Janssen LJ (2012) Airway smooth muscle as a target in asthma an de beneficial effects of bronchial thermoplasty. J Allergy (Cairo). https://doi.org/10.1155/2012/593784
Kirby M, Ohtani K, Lopez Lisbona RM, Lee AM, Zhang W, Lane P et al (2015) Bronchial thermoplasty in asthma: 2‑year follow-up using optical coherence tomography. Eur Respir J 46:859–862
Knight DA, Holgate ST (2003) The airway epithelium: structural and functional properties in health and disease. Respirology 8:432–446
Krimsky W, Sobieszczyk M, Sarkar S (2017) Thermal ablation for asthma: current status and technique. J Thorac Dis 9(Suppl 2):S104–S109
Lezmi G, Gosset P, Deschildre A, Abou-Taam R, Mahut B, Beydon N, de Blic J (2015) Airway remodeling in preschool children with severe recurrent wheeze. Am J Respir Crit Care Med 192:164–171
Mathew J, Aronow WS, Chandy D (2012) Therapeutic options for severe asthma. Arch Med Sci 8(4):589–597
Pavord ID, Cox G, Thomson NC, Rubin AS, Corris PA, Niven RM, Chung KF, Laviolette M, RISA Trial Study Group (2007) Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma. Am J Respir Crit Care Med 176(12):1185–1191
Pretolani M, Bergqvis A, Thabut G, Dombret MC, Knapp D, Hamidi F, Alavoine L, Taillé C, Chanez P, Erjefält JS, Aubier M (2016) Effectiveness of bronchial thermoplasty in patients with severe refractory asthma: clinical and histopathologic correlations. J Allergy Clin Immunol 139(4):1176–1185
Ryan DM, Fowler SJ, Niven RM (2016) Reduction in peripheral blood eosinophil counts after bronchial thermoplasty. J Allergy Clin Immunol 138:308–310
Scott GD, Fryer AD (2012) Role of parasympathetic nerves and muscarinic receptors in allergy and asthma. Chem Immunol Allergy 98:48–69
Sherikonda K, Sheshadri A, Koch T et al (2014) Predictors of bronchial thermoplasty response in patients with severe refractory asthma. Am J Respir Crit Care Med 189:A2429
Slebos DJ, Klooster K, Koegelenberg CF, Theron J, Styen D, Valipour A et al (2015) Targeted lung denervation for moderate to severe COPD: a pilot study. Thorax 70:411–419
Sweeney J, Patterson CC, Menzies-Gow A et al (2016) Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Astham Registry. Thorax 71:339–346
Thomson NC, Rubin AS, Niven RM, Corris PA, Siersted HC, Olivenstein R, Pavord ID, McCormack D, Laviolette M, Shargill NS, Cox G, AIR Trial Study Group (2011) Long-term (5-year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial. Bmc Pulm Med 11:11–18
Zein JG, Menegay MC, Singer ME, Erzurum SC, Gildea TR, Cicenia JC, Khatri S, Castro M, Ude BL (2016) Cost effectiveness of bronchial thermoplasty in patients with severe uncontrolled asthma. J Asthma 53(2):194–200
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
P. Kaukel gibt an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Additional information
Redaktion
M. Rolke, Aschaffenburg
Rights and permissions
About this article
Cite this article
Kaukel, P. Schweres Asthma: Interventionelle Therapieoptionen?. Pneumologe 15, 183–188 (2018). https://doi.org/10.1007/s10405-018-0168-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10405-018-0168-8